AGNG
Global X Aging Population ETF
$40.80
Global X Aging Population ETF (AGNG) Price & Chart
AGNG ETF Chart & Stats
$40.80
At close: 4:00 PM EST- Day’s Range
- $40.34 - $40.86
- 52-Week Range
- $33.92 - $41.64
- Previous Close
- $40.71
- Volume
- 13.23K
- Average Volume (3M)
- 8,739
- AUM
- 98.80M
- NAV
- 40.71
- Expense Ratio
- 0.50%
- Holdings Count
- 84
- Beta
- 0.47
- Inception Date
- May 09, 2016
- Last Dividend Ex-Date
- Jun 29, 2026
- Dividend Yield
- (0.80%)
- Shares Outstanding
- 2,429,849
- Standard Deviation
- N/A
ETF Overview
Global X Aging Population ETF
The Global X Aging Population ETF, trading under the ticker AGNG, is a unique investment vehicle designed to tap into the transformative demographic trend of a rapidly aging global population. This innovative exchange-traded fund falls within the 'Sector' category, with a distinct focus on thematic investment, specifically targeting the consumer niche. The ETF aims to capture growth opportunities stemming from the increasing demand for products and services tailored to the needs of older adults. AGNG invests in a carefully curated portfolio of companies poised to benefit from this demographic shift, including those in healthcare, pharmaceuticals, senior living facilities, and other industries that cater to aging populations. By doing so, the fund offers investors exposure to potential long-term growth driven by the rising consumption patterns and healthcare needs of seniors worldwide. As societies across the globe grapple with the economic and social implications of aging populations, the Global X Aging Population ETF provides a strategic opportunity for investors to align their portfolios with this powerful and enduring trend. This ETF not only capitalizes on the growing economic influence of older adults but also supports companies at the forefront of innovation and service delivery in this evolving market segment.
- Asset Class
- Equity
- Region
- Developed Markets
- Issuer
- Global X
- Index Tracked
- Indxx Aging Population Thematic Index
- Ticker Symbol
- AGNG
AGNG ETF News
Regeneron Updates Obesity Drug Study as Investors Await Results
Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals (NASDAQ: REGN) updated its Phase 2 study, officially titled “A Randomized, Double-Blind Study of The
7h agoREGN
AbbVie Crohn’s Disease Study Update Offers Limited Near-Term Stock Impact
Abbvie ($ABBV) announced an update on their ongoing clinical study. Study Overview: AbbVie’s official study, “A Post-marketing Non-interventional Study for Upadacitinib in Patients With Moderately to Severely Active Crohn’s Disease
7h agoABBV
AGNG ETF FAQ
What was AGNG’s price range in the past 12 months?
AGNG’s lowest price in the past 12 months was $33.92 and its highest was $41.64.
What is the AUM of AGNG?
As of Nov 11, 2026, the AUM of AGNG is $98.80M.
Is AGNG overvalued?
Based on Wall Street analyst price targets for AGNG’s holdings, AGNG’s price is currently undervalued.
Does AGNG pay dividends?
Yes. AGNG pays dividends semi-annually. Its most recent dividend was $0.16 per share, and its annual dividend yield is 0.80%. See more information on AGNG dividends here.
How many shares outstanding does AGNG have?
AGNG has 2,429,849 shares outstanding.
